EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY 4.0

Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer

T Lodhi, M Reardon, C G Quiles, A M Rojas, A Choudhury, P Hoskin

Clinical Oncology · 2026-06 · 54 · 104124

DOI: 10.1016/j.clon.2026.104124 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oncology, 2026-06. Verfasst von T Lodhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, University of Manchester, UK; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Neovascularization, Pathologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prostate Cancer UK, Movember Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyNeovascularization, PathologicMaleHumansAgedRadiotherapy DosageBiomarkers, TumorGene Expression ProfilingPrognosisMiddle Aged

Stichwörter der Autor:innen

BiomarkerBrachytherapyGene expressionHypoxiaProstate cancerRadiotherapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Division of Cancer Sciences, University of Manchester, UK; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, UK.
  • Division of Cancer Sciences, University of Manchester, UK.
  • Mount Vernon Cancer Centre, Northwood, UK.
  • Division of Cancer Sciences, University of Manchester, UK; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK. Electronic address: peterhoskin@nhs…

Förderung

  • Prostate Cancer UK
  • Movember Foundation

Zitieren

APA

Lodhi, T., Reardon, M., Quiles, C. G., Rojas, A. M., Choudhury, A., & Hoskin, P. (2026). Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer. Clinical Oncology, 54, 104124. https://doi.org/10.1016/j.clon.2026.104124

Vancouver

Lodhi T, Reardon M, Quiles CG, Rojas AM, Choudhury A, Hoskin P. Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer. Clinical Oncology. 2026;54:104124. doi:10.1016/j.clon.2026.104124

BibTeX
@article{Lodhi2026,
  author = {Lodhi, T and Reardon, M and Quiles, C G and Rojas, A M and Choudhury, A and Hoskin, P},
  title = {Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {54},
  pages = {104124},
  doi = {10.1016/j.clon.2026.104124}
}
Kostenlos starten →